Key Information About Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is an umbrella term for various long-term conditions that involve inflammation of the gut.
At the turn of the 21st century, IBD has become a global disease with accelerating incidence in newly industrialised nations whose societies have become more westernised.
IBD is not to be confused with IBS (Irritable Bowel Syndrome), which produces similar symptoms but without the visible damage to the digestive tract as is common with IBD.
Two main types of inflammatory bowel disease are ulcerative colitis and Crohn's disease.
Ulcerative colitis is limited to the large intestine. Crohn's disease can involve any part of the gastrointestinal tract; however, most commonly, it affects the last part of the small intestine or the colon or both.
Even though the exact cause of IBD is not known, some experts are of the opinion that these diseases are caused by a combination of genetic and non-genetic, or environmental factors that interact with the body's immune system.
When the intestinal immune system does not function properly, many WBCs accumulate in the inner lining of the gut. These cells then release chemicals that cause inflammation.
Both Crohn’s disease and ulcerative colitis usually involve severe diarrhea, stomach pain, fatigue, loss of appetite and weight loss.
PredictImmune's prognostic test for inflammatory bowel disease (IBD) is now available to clinicians and gastroenterologists in the U.K. and Ireland.
Inflammatory bowel disease is a chronic condition, and people with IBD will typically need treatment throughout their lives.
Treatment depends on how severe the symptoms are, and how much of the gut is affected.
The two goals of therapy are the achievement of remission (induction) and the prevention of disease flares (maintenance).
Medical therapy for IBD has advanced dramatically in the last 10 years with the introduction of targeted biologic therapies, the optimization of older therapies, including medicines like immunomodulators and 5-aminosalicylic acid (5-ASA), and a better understanding of the mucosal immune system and the genetics involved in the pathogenesis of IBD.
Entyvio therapy is safe for the long-term treatment of Crohn’s disease and ulcerative colitis, according to the final results of the GEMINI trial, presented at Digestive Disease Week.
Scientists at the University of Cambridge have developed a new test that can reliably predict the future course of inflammatory bowel disease in individuals, transforming treatments for patients and paving the way for a personalised approach.
Currently, health care providers commonly address the treatment of IBD based on how a patient is feeling at that specific point in time.
However, the approach to treatment is becoming forward-thinking, with practitioners choosing treatment paths based on how a patient’s disease will likely develop in the future.
Fitbit devices could help predict the flare-ups of inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, according to a new study published in the Journal of Crohn’s and Colitis. The year-long study, which was recently presented at Digestive Disease Week, was conducted by the University of Chicago.
Reducing the intake of certain foods, particularly meats and foods high in trans fats and refined sugar, can help lower your risk of getting IBD.
Include foods rich in dietary fiber (like berries and carrot) in your diet. Eat small, frequent meals; may be once every two hours. Drink plenty of liquids, especially water.
Carrot Is Rich in Dietary Fiber
Are foods rich in dietary fibers part of your diet?
This content is accurate and true to the best of the author’s knowledge and does not substitute for diagnosis, prognosis, treatment, prescription, and/or dietary advice from a licensed health professional. Drugs, supplements, and natural remedies may have dangerous side effects. If pregnant or nursing, consult with a qualified provider on an individual basis. Seek immediate help if you are experiencing a medical emergency.
© 2019 Srikanth R